Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation

Int J Hematol. 2005 Jun;81(5):439-40. doi: 10.1532/ijh97.05036.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / prevention & control*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Premedication
  • Risk Factors
  • Transplantation, Homologous

Substances

  • Antiviral Agents